Restoring the regenerative capacity of the aged muscle
恢复老化肌肉的再生能力
基本信息
- 批准号:10623204
- 负责人:
- 金额:$ 39.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAccelerationAdultAffectAgingAnimal ModelAnimalsArteriesBiochemical PathwayBiological AssayBiomedical EngineeringCell AgingCell TherapyCell modelCell physiologyCellsCollagen Type IIIDNA DamageDataDevelopmentDiseaseElastinElderlyEmbryoEngineeringExtracellular MatrixGenerationsGenesGoalsImpairmentIn VitroLaboratoriesMeasuresMediatingMedicalMesenchymal Stem CellsMetabolicMetabolismModelingMolecularMorbidity - disease rateMuscleMuscle FibersMuscle functionMyoblastsNatural regenerationOrganPatientsPhenotypePhysiologyPremature aging syndromeProgeriaQuality of lifeRegenerative MedicineRegenerative capacityRejuvenationReportingResearchResourcesRiskSignal PathwaySignal TransductionSkeletal MuscleSkeletal MyoblastsSkinSmooth Muscle MyocytesSystemTherapeuticTissue EngineeringTissuesWorkage effectage relatedagedaging populationanti agingcell agecell injurydesigndisabilitydruggable targetextracellularfollow-upfrailtyfunctional restorationhigh riskimprovedin vivoinducible gene expressioninnovationmechanical propertiesmortalitymouse modelmuscle agingmuscle formmuscle regenerationnew therapeutic targetnovelolder patientpluripotencyprogramsregeneration potentialregenerativeresponse to injurysarcopeniasenescenceskeletal muscle metabolismsmall moleculestem cellssuccesstherapy developmenttooltranscription factortranscriptometranscriptome sequencing
项目摘要
ABSTRACT
Age-related loss in muscle mass, sarcopenia, is a major medical problem facing the elderly and correlates with
loss of metabolic function, disabilities, morbidity, and mortality. In addition, prolonged culture times are required
to obtain the large numbers of cells necessary for regenerative medicine. As a result, the quality of the cells that
are used to engineer tissues for cell therapies may be compromised by replicative senescence.
In the past few years, our laboratory discovered that expression of a pluripotency-associated embryonic
transcription factor, NANOG, could reverse senescence and completely restore the differentiation potential of
senescent mesenchymal stem cells (MSC) and cells from progeria (accelerated aging disease) patients into
functional smooth muscle cells. We also discovered that NANOG could reverse the impaired ability of senescent
stem cells to produce collagen type III and elastin, which are severely affected by aging and affect the mechanical
properties of tissues such as skin, arteries and skeletal muscle. Most recently we discovered that NANOG
reversed the hallmarks of cellular senescence and restored the metabolic program of senescent skeletal
myoblasts, ultimately restoring their ability form contractile myotubes and regenerate in response to
injury.
In this proposal we seek to better understand the mechanisms that mediate the effect of NANOG in vitro and
in vivo through the following aims. In Aim 1, we will examine the effects of NANOG on myoblast senescence in
traditional cultures as well as using bioengineered 3D skeletal muscle tissues. NANOG is expressed after cells
reach senescence, thereby enabling us to measure the reversal of the aging phenotype using a plethora of
cellular, molecular and functional assays. In Aim 2, we will study the effects of NANOG on restoring the metabolic
function of aged myoblasts. We propose to study in detail the NANOG-induced metabolic reprogramming of
aged cells and investigate potential signaling pathways that may mediate these effects. Finally, in Aim 3 we will
develop a very innovative mouse model to investigate the effects of NANOG on animal physiology, skeletal
muscle metabolism and regeneration.
Impact: This is a very innovative proposal that seeks to investigate the potential of an embryonic
transcription factor to ameliorate the effects of aging and enhance the regenerative ability of aged skeletal muscle
(SkM). Understanding the mechanism(s) that mediate the effects of NANOG on metabolic reprogramming of
aged SkM may enable identification of novel druggable targets and design of innovative strategies to restore the
function of aged tissues. Given the surge in the aging population in the US and the world, the debilitating
effects of aging on skeletal muscle and the resulting frailty condition affecting the elderly, successful attainment
of this work may have significant impact in regenerative medicine and the quality of life of elderly patients.
抽象的
肌肉减少症与年龄相关的肌肉质量损失是老年人面临的主要医学问题,与
代谢功能,残疾,发病率和死亡率的丧失。另外,需要延长文化时间
获得再生医学所需的大量细胞。结果,细胞的质量
用于设计细胞疗法的组织可能会因复制衰老而受到损害。
在过去的几年中,我们的实验室发现多能相关的胚胎的表达
转录因子Nanog可以逆转衰老并完全恢复分化潜力
衰老间充质干细胞(MSC)和来自后代(加速衰老疾病)患者的细胞进入
功能平滑肌细胞。我们还发现Nanog可能会扭转衰老能力受损
干细胞产生III型胶原蛋白和弹性蛋白,这些胶原蛋白受到衰老的严重影响并影响机械
皮肤,动脉和骨骼肌等组织的特性。最近我们发现了Nanog
扭转了细胞衰老的标志,并恢复了衰老骨骼的代谢程序
成肌细胞,最终恢复其能力形成收缩的肌管,并在响应
受伤。
在这项建议中,我们试图更好地了解介导纳米在体外效果和的机制
通过以下目标进行体内。在AIM 1中,我们将检查Nanog对成肌细胞衰老的影响
传统培养物以及使用生物工程的3D骨骼肌组织。 Nanog在细胞后表达
到达衰老,从而使我们能够使用大量
细胞,分子和功能测定。在AIM 2中,我们将研究Nanog对恢复代谢的影响
老化成肌细胞的功能。我们建议详细研究Nanog诱导的代谢重编程
老化的细胞并研究可能介导这些作用的潜在信号通路。最后,在目标3中,我们将
开发一个非常创新的小鼠模型来研究纳米对动物生理,骨骼的影响
肌肉代谢和再生。
影响:这是一个非常创新的建议,旨在研究胚胎的潜力
转录因子可以改善衰老的影响并增强老化骨骼肌的再生能力
(SKM)。了解介导纳米对代谢重编程的影响的机制
老化的SKM可以鉴定新的可毒靶标和创新策略的设计,以恢复
老化组织的功能。鉴于美国和世界老龄化的人口激增,使人衰弱
衰老对骨骼肌的影响以及影响老年人的脆弱状况
这项工作可能会对再生医学和老年患者的生活质量产生重大影响。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fast photocurable thiol-ene elastomers with tunable biodegradability, mechanical and surface properties enhance myoblast differentiation and contractile function.
- DOI:10.1016/j.bioactmat.2020.12.022
- 发表时间:2021-07
- 期刊:
- 影响因子:18.9
- 作者:Mohamed MA;Shahini A;Rajabian N;Caserto J;El-Sokkary AMA;Akl MA;Andreadis ST;Cheng C
- 通讯作者:Cheng C
Reversine ameliorates hallmarks of cellular senescence in human skeletal myoblasts via reactivation of autophagy.
- DOI:10.1111/acel.13764
- 发表时间:2023-03
- 期刊:
- 影响因子:7.8
- 作者:
- 通讯作者:
Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells.
- DOI:10.1016/j.celrep.2022.111744
- 发表时间:2022-11-29
- 期刊:
- 影响因子:8.8
- 作者:
- 通讯作者:
Skeletal muscle reprogramming enhances reinnervation after peripheral nerve injury.
骨骼肌重编程可增强周围神经损伤后的神经支配。
- DOI:10.21203/rs.3.rs-3463557/v1
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Mehrotra,Pihu;Jablonski,James;Toftegard,John;Zhang,Yali;Shahini,Shahryar;Wang,Jianmin;Hung,CareyW;Ellis,Reilly;Kayal,Gabriella;Rajabian,Nika;Liu,Song;Roballo,Kelly;Udin,SusanB;Andreadis,SteliosT;Personius,KirkwoodE
- 通讯作者:Personius,KirkwoodE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stelios Theoharis Andreadis其他文献
Stelios Theoharis Andreadis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stelios Theoharis Andreadis', 18)}}的其他基金
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease
用于优化人类少突胶质细胞移植治疗脱髓鞘疾病的可编程水凝胶
- 批准号:
10737186 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别:
Cell-free vascular grafts: immunological response and vascular regeneration
无细胞血管移植物:免疫反应和血管再生
- 批准号:
10391437 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
Restoring the regenerative capacity of the aged muscle
恢复老化肌肉的再生能力
- 批准号:
10417266 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
Restoring the regenerative capacity of the aged muscle
恢复老化肌肉的再生能力
- 批准号:
10034130 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
Cell-free vascular grafts: immunological response and vascular regeneration
无细胞血管移植物:免疫反应和血管再生
- 批准号:
9912445 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
Restoring the regenerative capacity of the aged muscle
恢复老化肌肉的再生能力
- 批准号:
10241389 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
Cell-free vascular grafts: immunological response and vascular regeneration
无细胞血管移植物:免疫反应和血管再生
- 批准号:
10594428 - 财政年份:2020
- 资助金额:
$ 39.98万 - 项目类别:
High throughput genetic and functional screens for restoring stem cell potential
用于恢复干细胞潜力的高通量遗传和功能筛选
- 批准号:
9239040 - 财政年份:2017
- 资助金额:
$ 39.98万 - 项目类别:
Direct reprogramming of epidermal cells to neural crest derivatives for cell therapies
将表皮细胞直接重编程为神经嵴衍生物,用于细胞治疗
- 批准号:
9196190 - 财政年份:2016
- 资助金额:
$ 39.98万 - 项目类别:
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION
使用纤维蛋白水凝胶促进唾液腺再生
- 批准号:
10457818 - 财政年份:2012
- 资助金额:
$ 39.98万 - 项目类别:
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Activity-dependent endocannabinoid control in epilepsy
癫痫的活动依赖性内源性大麻素控制
- 批准号:
10639147 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别:
Heart-brain MRI for the evaluation of hemodynamic coupling in aging and Alzheimer's disease
心脑 MRI 用于评估衰老和阿尔茨海默氏病的血流动力学耦合
- 批准号:
10571411 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别:
Axonal Varicosity Dynamics in Central Neuron Mechanosensation and Injury
中枢神经元机械感觉和损伤中的轴突静脉曲张动力学
- 批准号:
10905596 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别:
Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue Sarcoma
超声引导超可控组织解剖阵列系统用于软组织肉瘤的无创治疗
- 批准号:
10649994 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别:
Velocity-Selective Arterial Spin Labeling based Perfusion Mapping for Alzheimer's disease
基于速度选择性动脉自旋标记的阿尔茨海默病灌注图
- 批准号:
10662909 - 财政年份:2023
- 资助金额:
$ 39.98万 - 项目类别: